Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 15

Page
per page
  1. Mitomycin C
    A4452 Mitomycin C
     3 Citation
    Summary: Inhibits DNA synthesis,antibiotic and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  2. Floxuridine
    A2402 Floxuridine
    Target: Synthases/Synthetases
    Summary: Antineoplastic antimetabolite
      ≥12.31 mg/mL
  3. Gemcitabine HCl
    A1402 Gemcitabine HCl
    Summary: Inhibits DNA synthesis,deoxycytidine analog
      ≥10.1 mg/mL
  4. Epirubicin HCl
    A2451 Epirubicin HCl
    Target: Topoisomerases
    Summary: Antibiotic antitumor agent
      ≥29.00 mg/mL
  5. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  6. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  7. Capecitabine
    A8647 Capecitabine
    Summary: DNA, RNA and protein synthesis inhibitor
      ≥10.97 mg/mL
  8. CRT0044876
    B3061 CRT0044876
    Target: AP endonucleases
    Summary: APE1 inhibitor, potent and selective
      ≥55.56 mg/mL
  9. BMH-21
    B4896 BMH-21
    Target: RNA Polymerases
    Summary: RNA polymerase I Inhibitior
      insoluble in EtOH; insoluble in H2O; ≥7.4 mg/mL
  10. Procarbazine HCl
    B1470 Procarbazine HCl
    Summary: Antineoplastic chemotherapy drug
      ≥12.82 mg/mL

Items 1-10 of 15

Page
per page